Model-driven mapping of transcriptional networks reveals the circuitry and dynamics of virulence regulation

Genome Research

Volumn 125, Issue 5, 2015, Pages 690-700

  Maier, Ezekiel J ^a,b   Haynes, Brian C ^a,b,c   Gish, Stacey R ^a   Wang, Zhuo A ^a   Skowyra, Michael L ^a   Marulli, Alyssa L ^a,d   Doering, Tamara L ^a   Brent, Michael R ^a,b  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WASHINGTON UNIVERSITY IN ST LOUIS   (United States)

^c ASURAGEN INC   (United States)

^d UNIVERSITY OF TOLEDO MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSCRIPTION FACTOR; VIRULENCE FACTOR; FUNGAL PROTEIN;

ANIMAL EXPERIMENT; ARTICLE; BIOLOGICAL PHENOMENA AND FUNCTIONS CONCERNING THE ENTIRE ORGANISM; BIOSYNTHESIS; CLIMATE; CONTROLLED STUDY; DELETION MUTANT; FUNGAL CAPSULE; FUNGAL VIRULENCE; GENE EXPRESSION PROFILING; GENE IDENTIFICATION; GENE MAPPING; MOLECULAR DYNAMICS; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; REGULATORY MECHANISM; ANIMAL; BIOLOGICAL MODEL; C57BL MOUSE; CHROMOSOMAL MAPPING; CRYPTOCOCCUS NEOFORMANS; FEMALE; GENE REGULATORY NETWORK; GENETICS; PATHOGENICITY; PROCEDURES;

FUNGI; MUS;

ANIMALS; CHROMOSOME MAPPING; CRYPTOCOCCUS NEOFORMANS; FEMALE; FUNGAL PROTEINS; GENE REGULATORY NETWORKS; MICE; MICE, INBRED C57BL; MODELS, GENETIC; TRANSCRIPTION FACTORS; VIRULENCE FACTORS;

EID: 84929657744     PISSN: 10889051     EISSN: 15495469     Source Type: Journal    
DOI: 10.1101/gr.184101.114     Document Type: Article

References (44)

1. Bahn YS, Kojima K, Cox GM, Heitman J. 2005. Specialization of the HOG pathway and its impact on differentiation and virulence of Cryptococcus neoformans. Mol Biol Cell 16: 2285-2300.
2. Bar-Peled M, Griffith CL, Doering TL. 2001. Functional cloning and characterization of a UDP-glucuronic acid decarboxylase: the pathogenic fungus Cryptococcus neoformans elucidates UDP-xylose synthesis. Proc Natl Acad Sci 98: 12003-12008.
3. Bar-Peled M, Griffith CL, Ory JJ, Doering TL. 2004. Biosynthesis of UDPGlcA, a key metabolite for capsular polysaccharide synthesis in the pathogenic fungus Cryptococcus neoformans. Biochem J 381: 131-136.
4. Chikamori M, Fukushima K. 2005. A new hexose transporter from Cryptococcus neoformans: molecular cloning and structural and functional characterization. Fungal Genet Biol 42: 646-655.
5. Chun CD, Brown JC, Madhani HD. 2011. A major role for capsule-independent phagocytosis-inhibitory mechanisms in mammalian infection by Cryptococcus neoformans. Cell Host Microbe 9: 243-251.
6. Coelho C, Bocca AL, Casadevall A. 2014. The tools for virulence of Cryptococcus neoformans. Adv Appl Microbiol 87: 1-41.
7. Cottrell TR, Griffith CL, Liu H, Nenninger AA, Doering TL. 2007. The pathogenic fungus Cryptococcus neoformans expresses two functional GDP-mannose transporters with distinct expression patterns and roles in capsule synthesis. Eukaryot Cell 6: 776-785.
8. Cramer KL, Gerrald QD, Nichols CB, Price MS, Alspaugh JA. 2006. Transcription factor Nrg1 mediates capsule formation, stress response, and pathogenesis in Cryptococcus neoformans. Eukaryot Cell 5: 1147-1156.
9. D'Souza CA, Alspaugh JA, Yue C, Harashima T, Cox GM, Perfect JR, Heitman J. 2001. Cyclic AMP-dependent protein kinase controls virulence of the fungal pathogen Cryptococcus neoformans. Mol Cell Biol 21: 3179-3191.
10. Eisenman HC, Casadevall A. 2012. Synthesis and assembly of fungal melanin. Appl Microbiol Biotechnol 93: 931-940.
11. Elemento O, Tavazoie S. 2005. Fast and systematic genome-wide discovery of conserved regulatory elements using a non-alignment based approach. Genome Biol 6: R18.
12. Erecinska M, Silver IA. 2001. Tissue oxygen tension and brain sensitivity to hypoxia. Respir Physiol 128: 263-276.
13. Fu J, Hettler E, Wickes BL. 2006. Split marker transformation increases homologous integration frequency in Cryptococcus neoformans. Fungal Genet Biol 43: 200-212.
14. Harbison CT, Gordon DB, Lee TI, Rinaldi NJ, Macisaac KD, Danford TW, Hannett NM, Tagne JB, Reynolds DB, Yoo J, et al. 2004. Transcriptional regulatory code of a eukaryotic genome. Nature 431: 99-104.
15. Haynes BC, Skowyra ML, Spencer SJ, Gish SR, Williams M, Held EP, Brent MR, Doering TL. 2011. Toward an integrated model of capsule regulation in Cryptococcus neoformans. PLoS Pathog 7: e1002411.
16. Haynes BC, Maier EJ, Kramer MH, Wang PI, Brown H, Brent MR. 2013. Mapping functional transcription factor networks from gene expression data. Genome Res 23: 1319-1328.
17. Hedges SB, Blair JE, Venturi ML, Shoe JL. 2004. A molecular timescale of eukaryote evolution and the rise of complex multicellular life. BMC Evol Biol 4: 2.
18. Hicks JK, Bahn YS, Heitman J. 2005. Pde1 phosphodiesterase modulates cyclic AMP levels through a protein kinase A-mediated negative feedback loop in Cryptococcus neoformans. Eukaryot Cell 4: 1971-1981.
19. Hu Z, Killion PJ, Iyer VR. 2007. Genetic reconstruction of a functional transcriptional regulatory network. Nat Genet 39: 683-687.
20. Janbon G, Ormerod KL, Paulet D, Byrnes EJIII, Yadav V, Chatterjee G, Mullapudi N, Hon CC, Billmyre RB, Brunel F, et al. 2014. Analysis of the genome and transcriptome of Cryptococcus neoformans var. grubii reveals complex RNA expression and microevolution leading to virulence attenuation. PLoS Genet 10: e1004261.
21. Jung WH, Sham A, White R, KronstadJW. 2006. Iron regulation of the major virulence factors in the AIDS-associated pathogen Cryptococcus neoformans. PLoS Biol 4: e410.
22. Kemmeren P, Sameith K, van de Pasch LA, Benschop JJ, Lenstra TL, Margaritis T, O'Duibhir E, Apweiler E, van Wageningen S, Ko CW, et al. 2014. Large-scale genetic perturbations reveal regulatory networks and an abundance of gene-specific repressors. Cell 157: 740-752.
23. Kronstad JW, Hu G, Choi J. 2011. The cAMP/protein kinase a pathway and virulence in Cryptococcus neoformans. Mycobiology 39: 143-150.
24. Kwon-Chung KJ, Fraser JA, Doering TL, Wang Z, Janbon G, Idnurm A, Bahn YS. 2014. Cryptococcus neoformans and Cryptococcus gattii, the etiologic agents of cryptococcosis. Cold Spring Harb Perspect Med 4: a019760.
25. Landt SG, Marinov GK, Kundaje A, Kheradpour P, Pauli F, Batzoglou S, Bernstein BE, Bickel P, Brown JB, Cayting P, et al. 2012. ChIP-seq guidelines and practices of the ENCODE and modENCODE consortia. Genome Res 22: 1813-1831.
26. Lee H, Chang YC, Varma A, Kwon-Chung KJ. 2009. Regulatory diversity of TUP1 in Cryptococcus neoformans. Eukaryot Cell 8: 1901-1908.
27. Liu X, Brutlag DL, Liu JS. 2001. BioProspector: discovering conserved DNA motifs in upstream regulatory regions of co-expressed genes. Pac Symp Biocomput 127-138.
28. Liu OW, Chun CD, Chow ED, Chen C, Madhani HD, Noble SM. 2008. Systematic genetic analysis of virulence in the human fungal pathogen Cryptococcus neoformans. Cell 135: 174-188.
29. Ma H, Hagen F, Stekel DJ, Johnston SA, Sionov E, Falk R, Polacheck I, Boekhout T, May RC. 2009. The fatal fungal outbreak on Vancouver Island is characterized by enhanced intracellular parasitism driven by mitochondrial regulation. Proc Natl Acad Sci 106: 12980-12985.
30. McGary KL, Park TJ, Woods JO, Cha HJ, Wallingford JB, Marcotte EM. 2010. Systematic discovery of nonobvious human disease models through orthologous phenotypes. Proc Natl Acad Sci 107: 6544-6549.
31. Moyrand F, Janbon G. 2004. UGD1, encoding the Cryptococcus neoformans UDP-glucose dehydrogenase, is essential for growth at 37C and for capsule biosynthesis. Eukaryot Cell 3: 1601-1608.
32. Moyrand F, Fontaine T, Janbon G. 2007. Systematic capsule gene disruption reveals the central role of galactose metabolism on Cryptococcus neoformans virulence. Mol Microbiol 64: 771-781.
33. Nielsen K, Cox GM, Litvintseva AP, Mylonakis E, Malliaris SD, Benjamin DKJr, Giles SS, Mitchell TG, Casadevall A, Perfect JR, et al. 2005. Cryptococcus neoformans strains preferentially disseminate to the central nervous system during coinfection. Infect Immun 73: 4922-4933.
34. O'Meara TR, Alspaugh JA. 2012. The Cryptococcus neoformans capsule: a sword and a shield. Clin Microbiol Rev 25: 387-408.
35. O'Meara TR, Xu W, Selvig KM,O'Meara MJ, Mitchell AP, Alspaugh JA. 2014. The Cryptococcus neoformans Rim101 transcription factor directly regulates genes required for adaptation to the host. Mol Cell Biol 34: 673-684.
36. Park BJ, Wannemuehler KA, Marston BJ, Govender N, Pappas PG, Chiller TM. 2009. Estimation of the current global burden of cryptococcal meningitis among persons living with HIV/AIDS. AIDS 23: 525-530.
37. SabiitiW, Robertson E, Beale MA, Johnston SA, Brouwer AE, Loyse A, Jarvis JN, Gilbert AS, Fisher MC, Harrison TS, et al. 2014. Efficient phagocytosis and laccase activity affect the outcome of HIV-associated cryptococcosis. J Clin Invest 124: 2000-2008.
38. Song MH, Lee JW, Kim MS, Yoon JK, White TC, Floyd A, Heitman J, Strain AK, Nielsen JN, Nielsen K, et al. 2012. A flucytosine-responsive Mbp1/Swi4-like protein, Mbs1, plays pleiotropic roles in antifungal drug resistance, stress response, and virulence of Cryptococcus neoformans. Eukaryot Cell 11: 53-67.
39. Spivak AT, Stormo GD. 2012. ScerTF: a comprehensive database of benchmarked position weight matrices for Saccharomyces species. Nucleic Acids Res 40: D162-D168.
40. Srikanta D, Santiago-Tirado FH, Doering TL. 2014. Cryptococcus neoformans: historical curiosity to modern pathogen. Yeast 31: 47-60.
41. Wang ZA, Griffith CL, Skowyra ML, Salinas N, Williams M, Maier EJ, Gish SR, Liu H, Brent MR, Doering TL. 2014. Cryptococcus neoformans dual GDP-mannose transporters and their role in biology and virulence. Eukaryot Cell 13: 832-842.
42. Zaman S, Lippman SI, Zhao X, Broach JR. 2008. How Saccharomyces responds to nutrients. Annu Rev Genet 42: 27-81.
43. Zaragoza O, Casadevall A. 2004. Experimental modulation of capsule size in Cryptococcus neoformans. Biol Proced Online 6: 10-15.
44. Zhu X, Williamson PR. 2003. A CLC-type chloride channel gene is required for laccase activity and virulence in Cryptococcus neoformans. Mol Microbiol 50: 1271-1281.